Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shane R Stecklein

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Breast (Edinburgh, Scotland)|July 12, 2023
Individualising radiation therapy decisions in breast cancer patients based on tumour infiltrating lymphocytes and genomic biomarkersMelanie Machiels, Redouane Oulkadi, Trine Tramm, et al.
Journal of Cancer Therapeutics & Research|September 2, 2014
The prognostic value of <i>BRCA1</i> promoter methylation in early stage triple negative breast cancerPriyanka Sharma, Shane R Stecklein, Bruce F Kimler, et al.
Annals of Surgical Oncology|August 3, 2017
Improved Locoregional Control in a Contemporary Cohort of Nonmetastatic Inflammatory Breast Cancer Patients Undergoing SurgeryKelly J Rosso, Audree B Tadros, Anna Weiss, et al.
Journal of Cancer|August 19, 2017
Lack of Breastfeeding History in Parous Women with Inflammatory Breast Cancer Predicts Poor Disease-Free SurvivalShane R Stecklein, Jay P Reddy, Adam R Wolfe, et al.
Breast Cancer Research and Treatment|November 1, 2022
EGFR as a potent CAR T target in triple negative breast cancer brain metastasesSiddharth Subham, John D Jeppson, Colette Worcester, et al.
JAMA Oncology|July 6, 2023
Radiotherapy Use and Incidence of Locoregional Recurrence in Patients With Favorable-Risk, Node-Positive Breast Cancer Enrolled in the SWOG S1007 TrialReshma Jagsi, William E Barlow, Wendy A Woodward, et al.
Practical Radiation Oncology|May 28, 2019
Excellent Locoregional Control in Inflammatory Breast Cancer With a Personalized Radiation Therapy ApproachShane R Stecklein, Kelly J Rosso, Jenny Nuanjing, et al.
International Journal of Radiation Oncology, Biology, Physics|June 22, 2018
Long-Term Impact of Regional Nodal Irradiation in Patients With Node-Positive Breast Cancer Treated With Neoadjuvant Systemic TherapyShane R Stecklein, Minjeong Park, Diane D Liu, et al.
NPJ Breast Cancer|March 6, 2023
ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual diseaseShane R Stecklein, Bruce F Kimler, Rachel Yoder, et al.
JCO Precision Oncology|November 16, 2023
Dual Prognostic Classification of Triple-Negative Breast Cancer by DNA Damage Immune Response and Homologous Recombination DeficiencyShane R Stecklein, William Barlow, Lajos Pusztai, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Breast (Edinburgh, Scotland)|July 12, 2023
Individualising radiation therapy decisions in breast cancer patients based on tumour infiltrating lymphocytes and genomic biomarkersMelanie Machiels, Redouane Oulkadi, Trine Tramm, et al.
Journal of Cancer Therapeutics & Research|September 2, 2014
The prognostic value of <i>BRCA1</i> promoter methylation in early stage triple negative breast cancerPriyanka Sharma, Shane R Stecklein, Bruce F Kimler, et al.
Annals of Surgical Oncology|August 3, 2017
Improved Locoregional Control in a Contemporary Cohort of Nonmetastatic Inflammatory Breast Cancer Patients Undergoing SurgeryKelly J Rosso, Audree B Tadros, Anna Weiss, et al.
Journal of Cancer|August 19, 2017
Lack of Breastfeeding History in Parous Women with Inflammatory Breast Cancer Predicts Poor Disease-Free SurvivalShane R Stecklein, Jay P Reddy, Adam R Wolfe, et al.
Breast Cancer Research and Treatment|November 1, 2022
EGFR as a potent CAR T target in triple negative breast cancer brain metastasesSiddharth Subham, John D Jeppson, Colette Worcester, et al.
JAMA Oncology|July 6, 2023
Radiotherapy Use and Incidence of Locoregional Recurrence in Patients With Favorable-Risk, Node-Positive Breast Cancer Enrolled in the SWOG S1007 TrialReshma Jagsi, William E Barlow, Wendy A Woodward, et al.
Practical Radiation Oncology|May 28, 2019
Excellent Locoregional Control in Inflammatory Breast Cancer With a Personalized Radiation Therapy ApproachShane R Stecklein, Kelly J Rosso, Jenny Nuanjing, et al.
International Journal of Radiation Oncology, Biology, Physics|June 22, 2018
Long-Term Impact of Regional Nodal Irradiation in Patients With Node-Positive Breast Cancer Treated With Neoadjuvant Systemic TherapyShane R Stecklein, Minjeong Park, Diane D Liu, et al.
NPJ Breast Cancer|March 6, 2023
ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual diseaseShane R Stecklein, Bruce F Kimler, Rachel Yoder, et al.
JCO Precision Oncology|November 16, 2023
Dual Prognostic Classification of Triple-Negative Breast Cancer by DNA Damage Immune Response and Homologous Recombination DeficiencyShane R Stecklein, William Barlow, Lajos Pusztai, et al.
Pageof 4